Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Amphastar P stock

Learn how to easily invest in Amphastar P stock.

Amphastar P
- $0.89 ( - 3.07%)

Amphastar P is a drug manufacturers-specialty & generic business based in the US. Amphastar P shares (AMPH) are listed on the NASDAQ and all prices are listed in US Dollars. Amphastar P employs 1,761 staff and has a trailing 12-month revenue of around $476.9 million.

How to buy shares in Amphastar P

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AMPH – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Amphastar P stock price (NASDAQ: AMPH)

Use our graph to track the performance of AMPH stocks over time.

Amphastar P shares at a glance

Information last updated 2022-09-25.
Latest market close$28.10
52-week range$18.12 - $44.46
50-day moving average $32.50
200-day moving average $31.47
Wall St. target price$40.67
PE ratio 15.4831
Dividend yield $0 (0%)
Earnings per share (TTM) $1.78

Buy Amphastar P shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Amphastar P stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Amphastar P price performance over time

Historical closes compared with the close of $28.1 from 2022-09-30

1 week (2022-09-23) 1.96%
1 month (2022-09-01) -5.39%
3 months (2022-07-01) -20.51%
6 months (2022-04-01) -24.89%
1 year (2021-09-27) 45.90%
2 years (2020-10-01) 47.58%
3 years (2019-10-01) 43.00%
5 years (2017-09-29) 57.25%

Is Amphastar P stock undervalued or overvalued?

Valuing Amphastar P stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amphastar P's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Amphastar P's P/E ratio

Amphastar P's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, Amphastar P shares trade at around 15x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Amphastar P's PEG ratio

Amphastar P's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.77. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Amphastar P's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Amphastar P's EBITDA

Amphastar P's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $120.8 million.

The EBITDA is a measure of a Amphastar P's overall financial performance and is widely used to measure a its profitability.

Amphastar P financials

Revenue TTM $476.9 million
Operating margin TTM 20.39%
Gross profit TTM $199.7 million
Return on assets TTM 8.75%
Return on equity TTM 19.1%
Profit margin 19.06%
Book value $10.19
Market capitalisation $1.4 billion

TTM: trailing 12 months

Amphastar P share dividends

We're not expecting Amphastar P to pay a dividend over the next 12 months.

Amphastar P share price volatility

Over the last 12 months, Amphastar P's shares have ranged in value from as little as $18.12 up to $44.46. A popular way to gauge a stock's volatility is its "beta".

AMPH.US volatility(beta: 0.73)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amphastar P's is 0.7339. This would suggest that Amphastar P's shares are less volatile than average (for this exchange).

Amphastar P overview

Amphastar Pharmaceuticals, Inc. , a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API.

Frequently asked questions

What percentage of Amphastar P is owned by insiders or institutions?
Currently 22.239% of Amphastar P shares are held by insiders and 63.518% by institutions.
How many people work for Amphastar P?
Latest data suggests 1,761 work at Amphastar P.
When does the fiscal year end for Amphastar P?
Amphastar P's fiscal year ends in December.
Where is Amphastar P based?
Amphastar P's address is: 11570 6th Street, Rancho Cucamonga, CA, United States, 91730
What is Amphastar P's ISIN number?
Amphastar P's international securities identification number is: US03209R1032
What is Amphastar P's CUSIP number?
Amphastar P's Committee on Uniform Securities Identification Procedures number is: 03209R103

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site